Back
Genmab A/S Stock Predictions
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
52
GMAB
Genmab A/S
Last Price:
$32.26
Seasonality Move:
2.79%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atGenmab A/S Stock Forecast
-
Over the next 52 weeks, Genmab A/S has on average historically risen by 34.7% based on the past 16 years of stock performance.
-
Genmab A/S has risen higher in 10 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
-
Is Genmab A/S Stock Undervalued?The current Genmab A/S [GMAB] share price is $32.25. The Score for GMAB is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
GMAB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Genmab A/S Stock Go Up Next Year?
-
Over the next 52 weeks, Genmab A/S has on average historically risen by 34.7% based on the past 16 years of stock performance.
Genmab A/S Stock Rating
Buy
52
Genmab A/S (GMAB)
is a Buy
Is Genmab A/S overpriced?
-
Genmab A/S has risen higher in 10 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
Genmab A/S Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com
52-Week Data
52-Week High:
35.43
52-Week Low:
17.24
Prediction Charts
Market Cap:
19.8B
Price in USD:
32.25
Volume:
6.2M
Beta:
0.70
Technical Analysis
SMA50:
31.73
SMA100:
30.55
SMA200:
25.88
52-Wk Change:
51.98%
Stock Predictions
-
Is Genmab A/S stock public?Yes, Genmab A/S is a publicly traded company.
-
What is the Genmab A/S stock quote today?The Genmab A/S stock price is 32.25 USD today.
-
How to buy Genmab A/S stock online?You can buy Genmab A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-29 | 32.89 | 32.52 | 33.00 | 32.51 |
| Dec-30 | 31.98 | 31.49 | 32.00 | 31.40 |
| Dec-31 | 31.42 | 30.80 | 31.50 | 30.35 |
| Jan-2 | 31.18 | 31.82 | 31.85 | 31.14 |
| Jan-5 | 32.09 | 31.80 | 32.10 | 31.29 |
| Jan-6 | 32.00 | 33.10 | 33.21 | 32.00 |
| Jan-7 | 33.11 | 33.90 | 33.99 | 33.08 |
| Jan-8 | 33.92 | 33.63 | 33.99 | 33.42 |
| Jan-9 | 33.61 | 34.26 | 34.30 | 33.57 |
| Jan-12 | 34.08 | 33.95 | 34.10 | 33.59 |
| Jan-13 | 33.48 | 33.87 | 33.90 | 33.30 |
| Jan-14 | 34.60 | 35.34 | 35.43 | 34.57 |
| Jan-15 | 34.60 | 33.85 | 34.62 | 33.52 |
| Jan-16 | 34.13 | 32.25 | 34.24 | 30.88 |
Genmab A/S Earnings
Genmab A/S Earnings Report: Per Share Genmab A/S Earnings Q1 Q2 Q3 and Q4 last year and next year.
Genmab A/S Forecast Revenue Growth
Genmab A/S Stock Analysis: Historical quarterly revenues per share for Genmab A/S and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.51 per share, and an increase next year of $0.79 per share.
* Genmab A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.